Vimab Group Past Earnings Performance

Past criteria checks 0/6

Key information

40.0%

Earnings growth rate

94.1%

EPS growth rate

Professional Services Industry Growth14.5%
Revenue growth rate14.3%
Return on equity-7.4%
Net Margin-1.2%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

We Think Vimab Group (STO:VIMAB) Is Taking Some Risk With Its Debt

Mar 14
We Think Vimab Group (STO:VIMAB) Is Taking Some Risk With Its Debt

Revenue & Expenses Breakdown
Beta

How Vimab Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:VIMAB Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23342-4840
30 Sep 23295-14770
30 Jun 23255-26630
31 Mar 23237-27610
31 Dec 22227-34570
30 Sep 22211-28550
31 Dec 21206-24560
31 Dec 20217-46450


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis


Return on Equity


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.